Dexrazoxane hydrochloride is a cardioprotective agent. It was discovered by Kurt
Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended ...
Dexrazoxane Injection: learn about side effects, dosage, special precautions, and
more on MedlinePlus.
Dexrazoxane. (deks-ray-ZOKS-ane). Trade name: Zinecard<sup>®</sup>. Chemocare.com
uses generic drug names in all descriptions of drugs. Zinecard is the trade name
FDA Statement on Dexrazoxane. [07-20-2011]. The United States Food and Drug
Administration (FDA) is informing the public that on June 23, 2011, the ...
Easy to read patient leaflet for dexrazoxane. Includes indications, proper use,
special instructions, precautions, and possible side effects.
May 14, 2013 ... Totect® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate intended
for intravenous (IV) administration. Totect® is packaged as ...
Expert Opin Investig Drugs. 2008 Feb;17(2):217-23. doi: 10.1517/13543784.17.
2.217. The use of dexrazoxane for the prevention of anthracycline extravasation ...
Jun 13, 2005 ... Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection
against anthracycline toxicity. It appears to inhibit formation of a ...
Medscape - Indication-specific dosing for Totect, Zinecard (dexrazoxane),
frequency-based adverse effects, comprehensive interactions, contraindications,
Dexrazoxane : a review of its use for cardioprotection during anthracycline
chemotherapy. Cvetković RS(1), Scott LJ. Author information: (1)Adis